Flow chart.

<p>Flow chart.</p

Box plots of LSM, FibroTest® and Fibrometer® scores according METAVIR stages from Liver Biopsy.

<p>Box plots of LSM, FibroTest® and Fibrometer® scores according METAVIR stages from Liver Biopsy.</p

Values of parameters used to scoring FibroTest® and Fibrometer® in the 7 patients with LSM<7 kPa and FibroTest® METAVIR scoring stages ≥F3.

<p><u>Normal values</u>: PT (prothrombin time):>70%, TB (total bilirubin): <20 µmol/L, GGT<73 IU/L, Platelets:>150 Giga/L, HA (Hyaluronic acid) <100 µg/L, Urea: 3.3–8.3 mmol/L, A2M (Alpha-2 macroglobulin): 1.3–3 g/L, Hapto (Haptoglobin): 0.64–1.7 g/L, ApoA1 ( Apolipoprotein A1): 1.04–2.02 g/L, ALT: 72 IU/L, AST: 59 IU/L.</p

Results of FT, FM METAVIR scoring stages according to Liver Stiffness Measurement values.

<p>Results of FT, FM METAVIR scoring stages according to Liver Stiffness Measurement values.</p

LSM values for each FibroTest® and Fibrometer® stage of fibrosis.

<p>LSM values for each FibroTest® and Fibrometer® stage of fibrosis.</p

Main characteristics of the 225 patients with CHB.

<p>*mean±SD,</p><p>**Median [IQ1–IQ3],</p><p>***F1–F2 considered as ≥F2.</p